Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development	$ 3,112	$ 4,468
General and administrative	3,436	1,269
Total operating expenses	6,548	5,737
Operating loss	(6,548)	(5,737)
Other income (expense)
Interest income	24	1
Interest expense	(478)	(306)
Other income (expense), net	(686)	(48)
Change in fair value of earn-out liability	10,757	0
Loss on debt extinguishment	0	492
Total other income (expense)	9,617	(845)
Net income (loss)	3,069	(6,582)
Comprehensive income (loss):
Other comprehensive loss	(50)	0
Comprehensive income (loss)	$ 3,019	$ (6,582)
Net income (loss) per share attributable to common shareholders:
Net income (loss) per share - Basic	$ 0.08	$ (4.55)
Net income (loss) per share - diluted	$ 0.07	$ (4.55)
Weighted-average common shares outstanding:
Weighted average common shares outstanding - basic	40,848,325	1,445,065
Weighted average common shares outstanding - diluted	43,382,444	1,445,065